Evaluation of the in vitro and in vivo effect of liposomal doxorubicin along with oncolytic Newcastle disease virus on 4T1 cell line: Animal preclinical research
Abstract Background Breast cancer is one of the most common malignancies in women, with one in 20 globally. Oncolytic viruses have recently been the first step in the biological treatment of cancer, either genetically engineered or naturally occurring. They increase specifically inside cancer cells...
Main Authors: | Pooya Faranoush, Alireza Jahandideh, Reza Nekouian, Pejman Mortazavi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-05-01
|
Series: | Veterinary Medicine and Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/vms3.1109 |
Similar Items
-
The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus
by: Upasana Pathak, et al.
Published: (2023-07-01) -
Exploration of the Delivery of Oncolytic Newcastle Disease Virus by Gelatin Methacryloyl Microneedles
by: Qiang Zhang, et al.
Published: (2024-02-01) -
Comparison between intratumoral and intravenously administered oncolytic virus therapy with Newcastle disease virus in a xenograft murine model for pancreatic adenocarcinoma
by: J. Fréderique de Graaf, et al.
Published: (2022-07-01) -
Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion
by: Noemi García-Romero, et al.
Published: (2020-06-01) -
Recent Preclinical and Clinical Progress in Liposomal Doxorubicin
by: Kenan Aloss, et al.
Published: (2023-03-01)